HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells.

Abstract
Transthyretin-Met 30 (TTR-Met 30) is a variant of transthyretin and is usually associated with familial amyloid polyneuropathy. It is rare that patients with TTR-Met 30 will primarily develop amyloid cardiomyopathy. This report presents a patient with late-onset TTR-Met 30 who primarily developed amyloid cardiomyopathy, with less amyloid polyneuropathy in the peripheral nervous system than is usually seen. An autopsy was performed, and histological examination revealed many foreign-body giant cells and macrophages in the area of amyloid deposition that was found in nearly all of the organs.
AuthorsY Nakamura, C Yutani, M Nakazato, Y Date, T Baba, Y Goto
JournalPathology international (Pathol Int) Vol. 49 Issue 10 Pg. 898-902 (Oct 1999) ISSN: 1320-5463 [Print] Australia
PMID10571824 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Prealbumin
  • Methionine
Topics
  • Aged
  • Amyloid Neuropathies (genetics, pathology)
  • Amyloidosis (complications, genetics)
  • Base Sequence
  • Cardiomyopathies (etiology, genetics, pathology)
  • Female
  • Giant Cells (cytology)
  • Heart Ventricles (pathology, ultrastructure)
  • Humans
  • Methionine (genetics)
  • Point Mutation
  • Prealbumin (genetics)
  • Rectum (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: